Denmark Leads New EU Task Force Exploring Use Of Big Data In Medicines Assessment
Executive Summary
EU drug regulators have created a new task force to establish a roadmap and recommendations on how to use big data in the assessment of medicines.
You may also be interested in...
Danish Agency Claims A First In Raw Data Analysis
The Danish Medicines Agency says it is about time that EU regulators developed US FDA-style capabilities to analyze raw data so that they can make better use of the opportunities provided by big data. Agency chief Thomas Senderovitz tells Medtech Insight how Denmark is setting up a unique data analytics center for medical devices and drugs without reinventing the wheel.
Danish Agency Claims A First In Raw Data Analysis
The Danish Medicines Agency says it is about time that EU regulators developed US FDA-style capabilities to analyze raw data so that they can make better use of the opportunities provided by big data. Agency chief Thomas Senderovitz tells the Pink Sheet how Denmark is setting up a unique data analytics center for drugs and devices without reinventing the wheel.
EU Big Data Report Takeaways Ready ‘In Weeks’
EU regulators have been working on a project to help determine the potential role of big data in medicines assessment for almost two years. They will soon be ready to release their keenly awaited conclusions.